Benelux: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Benelux

The Benelux market for other medicaments for therapeutic or prophylactic uses declined to $X in 2022, dropping by X% against the previous year. The total consumption indicated a modest expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption increased by X% against 2020 indices. The level of consumption peaked at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Benelux

In value terms, production of other medicaments for therapeutic or prophylactic uses expanded rapidly to $X in 2022 estimated in export price. In general, production, however, recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2015 with an increase of X% against the previous year. Over the period under review, production of attained the maximum level at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports in Benelux

In 2022, exports of other medicaments for therapeutic or prophylactic uses in Benelux skyrocketed to X tons, jumping by X% compared with the year before. In general, exports showed perceptible growth. The most prominent rate of growth was recorded in 2020 when exports increased by X%. As a result, the exports attained the peak of X tons. From 2021 to 2022, the growth of the exports of remained at a lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses declined to $X in 2022. Overall, exports, however, continue to indicate a mild descent. The growth pace was the most rapid in 2020 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X. From 2021 to 2022, the growth of the exports of failed to regain momentum.

Exports by Country

The shipments of the two major exporters of other medicaments for therapeutic or prophylactic uses, namely Belgium and the Netherlands, represented more than two-thirds of total export.

From 2012 to 2022, the biggest increases were recorded for Belgium (with a CAGR of X%).

In value terms, the Netherlands ($X) remains the largest other medicaments for therapeutic or prophylactic uses supplier in Benelux, comprising X% of total exports. The second position in the ranking was taken by Belgium ($X), with a X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of value in the Netherlands amounted to X%.

Export Prices by Country

In 2022, the export price in Benelux amounted to $X per ton, falling by X% against the previous year. In general, the export price recorded a abrupt contraction. The pace of growth was the most pronounced in 2017 an increase of X%. The level of export peaked at $X per ton in 2020; however, from 2021 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while Belgium stood at $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the Netherlands (X%).

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports in Benelux

In 2022, approx. X tons of other medicaments for therapeutic or prophylactic uses were imported in Benelux; increasing by X% against the year before. In general, imports recorded a modest expansion. The pace of growth appeared the most rapid in 2020 with an increase of X%. As a result, imports reached the peak of X tons. From 2021 to 2022, the growth of imports of failed to regain momentum.

In value terms, imports of other medicaments for therapeutic or prophylactic uses declined rapidly to $X in 2022. Overall, imports recorded temperate growth. The growth pace was the most rapid in 2020 when imports increased by X% against the previous year. As a result, imports reached the peak of $X. From 2021 to 2022, the growth of imports of remained at a somewhat lower figure.

Imports by Country

The Netherlands (X tons) and Belgium (X tons) represented roughly X% of total imports in 2022.

From 2012 to 2022, the biggest increases were recorded for Belgium (with a CAGR of X%).

In value terms, the Netherlands ($X) and Belgium ($X) constituted the countries with the highest levels of imports in 2022.

Among the main importing countries, the Netherlands, with a CAGR of X%, saw the highest growth rate of the value of imports, over the period under review.

Import Prices by Country

In 2022, the import price in Benelux amounted to $X per ton, waning by X% against the previous year. In general, the import price, however, enjoyed a noticeable expansion. The most prominent rate of growth was recorded in 2013 an increase of X%. The level of import peaked at $X per ton in 2018; however, from 2019 to 2022, import prices stood at a somewhat lower figure.

Average prices varied noticeably amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the Netherlands ($X per ton), while Belgium amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the Netherlands (X%).

Source: IndexBox Platform